10/26/2023: Business: DCGI approves MSD’s Keytruda for 2 more cancers

Posted On By
0 0
Read Time:12 Second

The Drugs Controller General of India has approved MSD’s Keytruda (pembrolizumab) in the treatment of triple­negative breast cancer (TNBC) and renal cell carcinoma (RCC) in adults. The approval will address a critical need for select patients, said…

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *